Naploy's Losses Shrink, Revenue Soars 525% Amid Going Concern Doubts

TL;DR

**Naploy's revenue surge is a mirage; the 'going concern' warning and dwindling cash mean this stock is a hard pass for now.**

AI Summary

Naploy Corp. reported a net loss of $7,223 for the three months ended October 31, 2025, a significant improvement from the $10,061 net loss in the same period of 2024. Revenue from services sales dramatically increased to $3,633 for the three months ended October 31, 2025, up from $581 in the prior year, representing a 525% increase. Despite this revenue growth, the company's accumulated deficit expanded to $54,618 as of October 31, 2025, from $47,395 on July 31, 2025, raising substantial doubt about its ability to continue as a going concern. Total assets decreased to $54,486 from $59,342, while total current liabilities rose to $72,837 from $70,470 over the same period. Cash and equivalents declined to $10,111 at October 31, 2025, from $12,717 at the beginning of the period. The company relies on a $59,921 loan from a related party, Mr. Rafael Angel Ulloa Bonilla, for working capital and plans to raise additional funds through private or public offerings.

Why It Matters

Naploy Corp.'s substantial revenue growth of 525% in service sales is a positive signal for investors, indicating potential market traction for its health news blog. However, the persistent net losses and growing accumulated deficit, coupled with a 'going concern' warning, present a high risk. Employees face uncertainty regarding the company's long-term stability, while customers might benefit from the expanding content if the company secures further funding. In the broader market, Naploy operates in a competitive digital media landscape, and its ability to raise capital will determine its viability against established players.

Risk Assessment

Risk Level: high — The company explicitly states 'substantial doubt about the Company's ability to continue as a going concern' due to an accumulated deficit of $54,618 and a net loss of $7,223 for the quarter. Cash and equivalents decreased by $2,606 to $10,111, indicating insufficient liquidity for daily operations without external funding.

Analyst Insight

Investors should avoid Naploy Corp. until it demonstrates a clear path to profitability and secures substantial, non-related-party funding. The 'going concern' warning and reliance on a related-party loan signal extreme financial instability.

Financial Highlights

debt To Equity

N/A

revenue

$3,633

operating Margin

N/A

total Assets

$54,486

total Debt

$59,921

net Income

$(7,223)

eps

$ (0.00)

gross Margin

N/A

cash Position

$10,111

revenue Growth

+525%

Revenue Breakdown

Key Numbers

• $3,633 — Services Sales Revenue (Increased from $581 in the prior year, a 525% increase)
• $(7,223) — Net Loss (Improved from $(10,061) in the prior year)
• $(54,618) — Accumulated Deficit (Increased from $(47,395) on July 31, 2025)
• $10,111 — Cash and Equivalents (Decreased from $12,717 on July 31, 2025)
• $59,921 — Loan from Related Party (Outstanding and payable upon request, used for working capital)
• 3,803,370 — Common Shares Outstanding (As of October 31, 2025)
• $54,486 — Total Assets (Decreased from $59,342 on July 31, 2025)
• $72,837 — Total Current Liabilities (Increased from $70,470 on July 31, 2025)
• $2,250 — Amortization Expense (Consistent across both periods, related to intangible assets)
• $8,586 — Professional Fees (Increased from $8,365 in the prior year)

Key Players & Entities

• Naploy Corp. (company) — registrant
• Rafael Angel Ulloa Bonilla (person) — Director and related party lender
• Frederick Sidney Reinhard Arnold (person) — Director and common stock recipient
• Wise (company) — financial technology company holding cash
• SEC (regulator) — Securities and Exchange Commission
• Wyoming (regulator) — State of incorporation
• Goldman Sachs Bank USA (company) — bank holding Wise's funds
• JPMorgan Chase Bank, N.A. (company) — bank holding Wise's funds
• Wells Fargo Bank, N.A. (company) — bank holding Wise's funds

FAQ

Risk Factors

• Going Concern Uncertainty [high — financial]: The company's accumulated deficit increased to $54,618 as of October 31, 2025, from $47,395 on July 31, 2025. Total assets decreased to $54,486 from $59,342, and cash and equivalents declined to $10,111. This raises substantial doubt about Naploy Corp.'s ability to continue as a going concern.
• Reliance on Related Party Loan [high — financial]: The company relies heavily on a $59,921 loan from a related party, Mr. Rafael Angel Ulloa Bonilla, for working capital. This concentration of debt with a related party poses a risk if the loan terms are not favorable or if repayment becomes an issue.
• Inability to Fund Operations [high — financial]: Despite revenue growth, the company continues to incur net losses ($7,223 for the three months ended October 31, 2025). The company plans to raise additional funds through offerings, but there is no guarantee of success, potentially hindering future operations.
• Limited Operational History [medium — operational]: Naploy Corp. was incorporated on April 6, 2023, and has incurred losses since inception. The company has no employees, relying solely on its officers and directors. This limited operational history and lack of personnel may impede its ability to execute its business plan.
• Dependence on App Performance [medium — market]: The company's primary focus is on its Naploy App, which offers a news blog and a symptom diagnostic tool. The success of the company is directly tied to the performance, user adoption, and monetization of this app.
• Healthcare Information Accuracy [medium — regulatory]: The Naploy App provides health-related information and a symptom diagnostic tool. Ensuring the accuracy and reliability of this information is critical, as inaccuracies could lead to user harm and potential regulatory scrutiny or legal action.

Industry Context

The healthcare information and technology sector is rapidly evolving, driven by increased digital adoption and a focus on accessible health data. Companies like Naploy Corp. aim to leverage AI and mobile platforms to provide diagnostic tools and health news. However, this space is competitive, with established players and startups vying for user attention and market share. Regulatory scrutiny regarding data privacy and the accuracy of health information is also a significant factor.

Regulatory Implications

Naploy Corp. operates in the healthcare information space, which is subject to regulations concerning data privacy (e.g., HIPAA in the US, though the company's location is Nigeria) and the accuracy of medical information. Providing a symptom diagnostic tool requires careful consideration of potential liabilities arising from misdiagnoses or incorrect advice. Compliance with evolving data protection laws and ethical guidelines for AI in healthcare is crucial.

What Investors Should Do

1. Monitor cash burn and funding efforts
2. Assess the sustainability of revenue growth
3. Evaluate the terms of the related party loan
4. Scrutinize the Naploy App's user adoption and monetization strategy

Key Dates

• 2025-10-31: End of Q3 2025 reporting period — Naploy Corp. reported a net loss of $7,223 and an accumulated deficit of $54,618, highlighting ongoing financial challenges despite revenue growth.
• 2025-07-31: End of Q2 2025 reporting period — Naploy Corp. reported an accumulated deficit of $47,395 and total assets of $59,342, serving as a baseline for the subsequent period's deterioration.
• 2023-04-06: Company Incorporation — Marks the official start of Naploy Corp.'s operations, from which it has consistently incurred losses.

Glossary

Accumulated Deficit

The total net losses a company has incurred since its inception, minus any net income. It represents a negative balance in retained earnings. (Naploy Corp.'s accumulated deficit has grown to $(54,618), indicating persistent unprofitability and a significant erosion of equity.)

Going Concern

A business's ability to continue operating for the foreseeable future without the threat of liquidation. Auditors assess this based on financial health and operational viability. (The company's financial condition, including its increasing deficit and declining assets, raises substantial doubt about its ability to continue as a going concern.)

Intangible Assets, Net

Non-physical assets that have value, such as patents, copyrights, and goodwill, net of accumulated amortization. (Naploy Corp. has $24,375 in net intangible assets, which decreased from $26,625, likely due to amortization expense.)

Amortization Expense

The systematic allocation of the cost of an intangible asset over its useful life. (Consistent amortization expense of $2,250 is recognized, related to the company's intangible assets.)

Deferred Revenue

Revenue that has been received by a company for goods or services that have not yet been delivered or rendered. (Deferred revenue increased to $12,817 from $10,450, suggesting an increase in customer payments for future services or subscriptions.)

Year-Over-Year Comparison

Naploy Corp. has demonstrated a significant 525% increase in Services Sales Revenue, rising from $581 to $3,633 for the three months ended October 31, 2025. This revenue growth has also led to a reduction in the net loss, from $(10,061) to $(7,223). However, despite this top-line improvement, the company's financial precariousness has worsened. Total assets have decreased from $59,342 to $54,486, and the accumulated deficit has expanded from $(47,395) to $(54,618), intensifying concerns about its going concern status. Current liabilities have also edged up, while cash reserves have dwindled.

Key Financial Figures

• $0.0001 — Stockholders Deficit Common stock, $0.0001 par value, 75,000,000 shares authorized
• $0.02 — stock for cash proceeds of $ 34,692 at $0.02 per share. During the year ended July

Filing Documents

• naploy_i10q-103125.htm (10-Q) — 303KB
• naploy_ex3101.htm (EX-31.1) — 12KB
• naploy_ex3201.htm (EX-32.1) — 5KB
• 0001683168-25-008792.txt ( ) — 1917KB
• none-20251031.xsd (EX-101.SCH) — 15KB
• none-20251031_def.xml (EX-101.DEF) — 35KB
• none-20251031_lab.xml (EX-101.LAB) — 161KB
• none-20251031_pre.xml (EX-101.PRE) — 128KB
• none-20251031_cal.xml (EX-101.CAL) — 22KB
• naploy_i10q-103125_htm.xml (XML) — 135KB

Financial Statements (Unaudited)

Financial Statements (Unaudited) 3 Balance Sheet as of October 31, 2025 (Unaudited) and July 31, 2025 4 5 6 7 Notes to the Unaudited Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 14 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 22 Item 4.

Controls and Procedures

Controls and Procedures 22 PART II OTHER INFORMATION: Item 1.

Legal Proceedings

Legal Proceedings 23 Item 1A.

Risk Factors

Risk Factors 23 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 23 Item 3. Defaults Upon Senior Securities 23 Item 4. Mine Safety Disclosures 23 Item 5. Other Information 23 Item 6. Exhibits 23

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements The accompanying interim financial statements of Naploy Corp. ("the Company", "we", "us" or "our"), have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission. The interim financial statements are condensed and should be read in conjunction with the company's latest annual financial statements. In the opinion of management, the financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented. 3 NAPLOY CORP. BALANCE SHEETS October 31, 2025 (Unaudited) July 31, 2025 (Audited) ASSETS Cash $ 10,111 $ 12,717 Prepaid Expenses 20,000 20,000 Total Current Assets 30,111 32,717 Intangible Assets, Net 24,375 26,625 Total Assets $ 54,486 $ 59,342 LIABILITIES & STOCKHOLDERS' EQUITY/(DEFICIT) Liabilities Accounts Payable $ 99 $ 99 Accounts Payable – Related Party 59,921 59,921 Deferred Revenue 12,817 10,450 Total Current Liabilities 72,837 70,470 Stockholders Deficit Common stock, $0.0001 par value, 75,000,000 shares authorized; 3,803,370 and 3,803,370 shares issued and outstanding as of October 31, 2025 and July 31, 2025, respectively 380 380 Additional Paid in Capital 35,887 35,887 Accumulated deficit ( 54,618 ) ( 47,395 ) Total Stockholders' Equity/(Deficit) ( 18,351 ) ( 11,128 ) Total Liabilities and Stockholders' Equity/(Deficit) $ 54,486 $ 59,342 The accompanying notes are an integral part of these unaudited financial statements. 4 NAPLOY CORP. Three months ended October 31, 2025 and 2024 Three months period ended October 31, 2025 (Unaudited) Three months period ended October 31, 2024 (Unaudited) REVENUES Services Sales $ 3,633 $ 581 Total Revenues 3,633 581 OPERATING EXPENSES Amort

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations DESCRIPTION OF BUSINESS GENERAL Naploy Corp. (referred as the "Company", "we", "our") was incorporated in the State of Wyoming and established on April 6, 2023. The Company has no sufficient revenue and has incurred losses since inception. Our primary focus is on launching a news blog that provides the latest updates on health-related topics, including but not limited to medical breakthroughs, healthy lifestyle tips, and updates on healthcare policies. We have developed a full business plan. Currently, we have no employees, only our officers and Directors - Mr. Frederick Sidney Reinhard Arnold and Mr. Rafael Angel Ulloa Bonilla. Our executive and business office is located at 95 Lias Estate Kafe district Abuja, FCT 900108 Nigeria, and our telephone number is +13072133163. The COVID-19 pandemic has had a significant impact on the healthcare industry and has led to changes in the way healthcare services are delivered, including through mobile applications that offer online information help services for finding medical institutions. Here are some ways the pandemic has affected these types of apps: Increased demand: The pandemic has increased the demand for healthcare services, and many people have turned to mobile apps to find information about medical institutions and services. Safety concerns: Many people are hesitant to visit medical institutions in person due to safety concerns, and mobile apps that offer information about medical institutions and their safety protocols can help alleviate these concerns. Our Naploy App is your go-to source for the latest health news and updates. Naploy App offers an article library- News Blog that deals with the most common health topics. Our health blog covers diverse health related concerns such as nutrition and diet, fitness, weight control, diseases, disease management, societal trends affecting health, analysis about health, busine

View Full Filing

View this 10-Q filing on SEC EDGAR